Omega-3 fatty acids supplementation for autism spectrum disorders (ASD) (Q24235241)

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Role of polyunsaturated fatty acids in the management of Egyptian children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Omega 3 fatty acid treatment in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Behavioral effects of omega-3 fatty acid supplementation in young adults with severe autism: an open label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

The responses of autistic children to the distress of others.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Emotion recognition in children with autism spectrum disorders: relations to eye gaze and autonomic state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Essential fatty acids and phospholipase A2 in autistic spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Omega-3 fatty acids for autistic spectrum disorder: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Assessing the early characteristics of autistic disorder using video analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Gaze fixation and the neural circuitry of face processing in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

High omega-3 fatty acid content in alpine cheese: the basis for an alpine paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Hello and goodbye: a study of social engagement in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Frequency and latency of social interaction in an inclusive kindergarten setting: a comparison between typical children and children with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Risperidone for autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Diagnosis of autism spectrum disorders in the first 3 years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Bullying among children with autism and the influence of comorbidity with ADHD: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Pharmacotherapeutic management of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Update on the language disorders of individuals on the autistic spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Omega-3 fatty acids in ADHD and related neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Incidence of autism spectrum disorders: Changes over time and their meaning*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

The importance of the ratio of omega-6/omega-3 essential fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Importance of the Ratio of Omega-6/Omega-3 Essential Fatty Acids: Evolutionary Aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Abnormal use of facial information in high-functioning autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Epidemiology of Infantile Autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Plasma fatty acid levels in autistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Essential fatty acids and the brain: from infancy to aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

Diagnostic and Assessment Issues in Autism Surveillance and Prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

7 January 2021

ABA and Students with Autism Spectrum Disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

7 January 2021

Fatty acid composition, including conjugated linoleic acid, of intramuscular fat from steers offered grazed grass, grass silage, or concentrate-based diets

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

7 January 2021

Evidence that eicosapentaenoic acid is effective in treating autism.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007992.PUB2

7 January 2021

10.1002/14651858.CD007992.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4659005

Fatcat ID

release_4a2qbkig4vb55bcqnfruauwehu

0 references

OpenCitations bibliographic resource ID

4659005

1 reference